BensaAPrevitaliDSangiorgioA, et al. PRP injections for the treatment of knee osteoarthritis: the improvement is clinically significant and influenced by platelet concentration. A meta-analysis of randomized controlled trials. Am J Sports Med. 2025;53(3):745-754.
2.
BoffaADe MarzianiLAndrioloL, et al. Influence of platelet concentration on the clinical outcome of platelet-rich plasma injections in knee osteoarthritis. Am J Sports Med. 2024;52(13):3223-3231.
3.
CavalloCRoffiAGrigoloB, et al. Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed Res Int. 2016;2016:6591717.
4.
Gazzetta Ufficiale della Repubblica Italiana. Provisions relating to blood quality and safety requirements and blood components. December 28, 2015. Accessed July 13, 2023. Available at: https://www.gazzettaufficiale.it/eli/id/2015/12/28/15A09709/sg.
5.
KonEde GirolamoLLaverL, et al. Platelet-rich plasma injections for the management of knee osteoarthritis: the ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surg Sports Traumatol Arthrosc. 2024;32(11):2938-2949.
6.
LaverLFilardoGSanchezM, et al. The use of injectable orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus. Part 1: blood-derived products (platelet-rich plasma). Knee Surg Sports Traumatol Arthrosc. 2024;32(4):783-797.
7.
RoffiAFilardoGAssirelliE, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?Biomed Res Int. 2014;2014:692913.
